关注
Umar Mehraj
Umar Mehraj
Department of Pathology, Duke University
在 duke.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Tumor microenvironment promotes breast cancer chemoresistance
U Mehraj, AH Dar, NA Wani, MA Mir
Cancer chemotherapy and pharmacology 87 (2), 147-158, 2021
1812021
The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities
U Mehraj, RA Ganai, MA Macha, A Hamid, MA Zargar, AA Bhat, ...
Cellular Oncology, 1-21, 2021
822021
Targeting Different Pathways Using Novel Combination Therapy in Triple Negative Breast Cancer
MA Mir, H Qayoom, U Mehraj, S Nisar, B Bhat, NA Wani
Current Cancer Drug Targets 20 (8), 586-602, 2020
792020
Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors
S Sofi, U Mehraj, H Qayoom, S Aisha, A Almilaibary, M Alkhanani, MA Mir
Medical Oncology 39 (9), 133, 2022
752022
Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications
S Sofi, U Mehraj, H Qayoom, S Aisha, SMB Asdaq, A Almilaibary, MA Mir
Medical Oncology 39 (6), 106, 2022
672022
Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives
U Mehraj, H Qayoom, MA Mir
Breast Cancer 28 (3), 539-555, 2021
632021
Nanobodies: The “magic bullets” in therapeutics, drug delivery and diagnostics
MA Mir, U Mehraj, BA Sheikh, SS Hamdani
Human antibodies 28 (1), 29-51, 2020
582020
Expression pattern and prognostic significance of baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5) in breast cancer: A comprehensive analysis
U Mehraj, S Aisha, S Sofi, MA Mir
Advances in Cancer Biology-Metastasis, 100037, 2022
452022
Double-crosser of the Immune System: Macrophages in Tumor Progression and Metastasis
MA Mir, U Mehraj
Current Immunology Reviews 15 (2), 172-184, 2019
452019
Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications
U Mehraj, U Mushtaq, MA Mir, A Saleem, MA Macha, MN Lone, A Hamid, ...
Seminars in Cancer Biology 86, 769-783, 2022
442022
Development of new therapeutics to meet the current challenge of drug resistant tuberculosis
BA Sheikh, BA Bhat, U Mehraj, W Mir, S Hamadani, MA Mir
Current Pharmaceutical Biotechnology 22 (4), 480-500, 2021
412021
Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study
H Qayoom, U Mehraj, S Sofi, S Aisha, A Almilaibary, M Alkhanani, MA Mir
Medical Oncology 39 (10), 158, 2022
322022
Expression pattern and prognostic significance of chemokines in breast cancer: an integrated bioinformatics analysis
U Mehraj, B Alshehri, AA Khan, AA Bhat, P Bagga, NA Wani, MA Mir
Clinical Breast Cancer 22 (6), 567-578, 2022
292022
Expression pattern and prognostic significance of CDKs in breast cancer: an integrated bioinformatic study
U Mehraj, S Sofi, B Alshehri, MA Mir
Cancer Biomarkers 34 (3), 505-519, 2022
282022
Adapalene and doxorubicin synergistically promote apoptosis of TNBC Cells by hyperactivation of the ERK1/2 pathway through ROS induction
U Mehraj, IA Mir, M Hussain, M Alkhanani, NA Wani, MA Mir
Frontiers in oncology 12, 938052, 2022
262022
Recent Advances in Metabolites from Medicinal Plants in Cancer Prevention and Treatment
MA Mir, SS Hamdani, BA Sheikh, U Mehraj
Current Immunology Reviews 15 (2), 185-201, 2019
252019
Rising trends of cancers in Kashmir valley: distribution pattern, incidence and causes
H Qayoom, BA Bhat, U Mehraj, MA Mir
J Oncol Res Treat 5 (150), 2, 2020
232020
Cryptolepine targets TOP2A and inhibits tumor cell proliferation in breast cancer cells-an in vitro and in silico study
U Mehraj, H Qayoom, S Shafi, P Farhana, S Asdaq, MA Mir
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2022
222022
Adapalene inhibits the growth of triple-negative breast cancer cells by S-phase arrest and potentiates the antitumor efficacy of GDC-0941
U Mehraj, NA Wani, A Hamid, M Alkhanani, A Almilaibary, MA Mir
Frontiers in pharmacology 13, 958443, 2022
212022
Recent advances in chemotherapeutic implications of deguelin: a plant-derived retinoid
MA Mir, U Mehraj, BA Sheikh
The Natural Products Journal 11 (2), 169-181, 2021
172021
系统目前无法执行此操作,请稍后再试。
文章 1–20